Combination of unsaturated fatty acids and ionizing radiation on human glioma cells: Cellular, biochemical and gene expression analysis

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Antal, Otilia ^a   Hackler, László ^b   Shen, Junhui ^c   Mán, Imola ^b   Hideghéty, Katalin ^d   Kitajka, Klára ^a,b   Puskás, László G ^a,b  

^a INSTITUTE OF BIOCHEMISTRY   (Hungary)

^b AVIDIN LTD   (Hungary)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Gene expression; Glioma; Irradiation; miRNA expression; Polyunsaturated fatty acids (PUFAs)

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; MICRORNA; MICRORNA 146A; MICRORNA 181A; OLEIC ACID; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; LACTATE DEHYDROGENASE; TRANSCRIPTOME; UNSATURATED FATTY ACID;

AKR1C1 GENE; ARTICLE; CANCER CELL LINE; CYTOCHEMISTRY; EARLY GROWTH RESPONSE FACTOR 1 GENE; FOSL1 GENE; GADD45A GENE; GENE EXPRESSION; GLIOMA CELL; GLUCOSE REGULATED PROTEIN 78 GENE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153 GENE; HEME OXYGENASE 1 GENE; HUMAN; HUMAN CELL; IONIZING RADIATION; NOTCH1 RECEPTOR GENE; NQO1 GENE; ONCOGENE C MYC; PROTEIN P53 GENE; TUMOR NECROSIS FACTOR ALPHA GENE; CELL PROLIFERATION; CELL SHAPE; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; METABOLISM; RADIATION RESPONSE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; DRUG SCREENING ASSAYS, ANTITUMOR; FATTY ACIDS, UNSATURATED; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; L-LACTATE DEHYDROGENASE; MICRORNAS; TRANSCRIPTOME;

EID: 84908161732     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-142     Document Type: Article

References (69)

1. Ford E, Catt S, Chalmers A, Fallowfield L: Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro Oncol 2012, 14:392-404.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996.
3. Mirimanoff RO: High-grade gliomas: reality and hopes. Chin J Cancer 2014, 33:1-3.
4. van den Bent MJ, Snijders TJ, Bromberg JE: Current treatment of low grade gliomas. Memo 2012, 5:223-227.
5. Hardee ME, Marciscano AE, Medina-Ramirez CM, Zagzag D, Narayana A, Lonning SM, Barcellos-Hoff MH: Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β. Cancer Res 2012, 72:4119-4129.
6. Leaver HA, Bell HS, Rizzo MT, Ironside JW, Gregor A, Wharton SB, Whittle IR: Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma. Prostaglandins Leukot Essent Fatty Acids 2002, 66:19-29.
7. Faragó N, Fehér LZ, Kitajka K, Das UN, Puskás LG: MicroRNA profile of polyunsaturated fatty acid treated glioma cells reveal apoptosis-specific expression changes. Lipids Health Dis 2011, 10:173.
8. Colquhoun A: Lipids, mitochondria and cell death: implications in neurooncology. Mol Neurobiol 2010, 42:76-88.
9. Heyd VL, Eynard AR: Effects of eicosatrienoic acid (20:3 n-9, Mead's acid) on some promalignant-related properties of three human cancer cell lines. Prostaglandins Other Lipid Mediat 2003, 71:177-188.
10. Das UN: From bench to the clinic: gamma-linolenic acid therapy of human gliomas. Prostaglandins Leukot Essent Fatty Acids 2004, 70:539-552.
11. Das UN: Gamma-linolenic acid therapy of human glioma-a review of in vitro, in vivo, and clinical studies. Med Sci Monit 2007, 13:119-132.
12. Das UN, Prasad VV, Reddy DR: Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett 1995, 94:147-155.
13. Leaver HA, Wharton SB, Bell HS, Leaver-Yap IM, Whittle IR: Highly unsaturated fatty acid induced tumour regression in glioma pharmacodynamics and bioavailability of gamma linolenic acid in an implantation glioma model: effects on tumour biomass, apoptosis and neuronal tissue histology. Prostaglandins Leukot Essent Fatty Acids 2002, 67:283-292.
14. Sandrone SS, Repossi G, Candolfi M, Eynard AR: Polyunsaturated fatty acids and gliomas: A critical review of experimental, clinical, and epidemiologic data. Nutrition 2014, S0899-9007:00075-00076.
15. Leary WP, Robinson KM, Booyens J, Dippenaar N: Some effects of gamma-linolenic acid on cultured human oesophageal carcinoma cells. S Afr Med J 1982, 62:681-683.
16. Finocchiaro C, Segre O, Fadda M, Monge T, Scigliano M, Schena M, Tinivella M, Tiozzo E, Catalano MG, Pugliese M, Fortunati N, Aragno M, Muzio G, Maggiora M, Oraldi M, Canuto RA: Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. Br J Nutr 2012, 108:327-333.
17. Biondo PD, Brindley DN, Sawyer MB, Field CJ: The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. J Nutr Biochem 2008, 19:787-796.
18. Puskás LG, Fehér LZ, Vizler C, Ayaydin F, Rásó E, Molnár E, Magyary I, Kanizsai I, Gyuris M, Madácsi R, Fábián G, Farkas K, Hegyi P, Baska F, Ozsvári B, Kitajka K: Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells. Lipids Health Dis 2010, 9:56.
19. Germain E, Chajès V, Cognault S, Lhuillery C, Bougnoux P: Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. Int J Cancer 1998, 75:578-583.
20. De Carlo F, Witte TR, Hardman WE, Claudio PP: Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy. PLoS One 2013, 8:e69760.
21. Wen B, Deutsch E, Opolon P, Auperin A, Frascogna V, Connault E, Bourhis J: N-3 polyunsaturated fatty acids decrease mucosal/epidermal reactions and enhance antitumour effect of ionising radiation with inhibition of tumour angiogenesis. Br J Cancer 2003, 89:1102-1107.
22. Colas S, Paon L, Denis F, Prat M, Louisot P, Hoinard C, Le Floch O, Ogilvie G, Bougnoux P: Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid. Int J Cancer 2004, 109:449-454.
23. Ozsvári B, Puskás LG, Nagy LI, Kanizsai I, Gyuris M, Madácsi R, Fehér LZ, Gerö D, Szabó C: A cell-microelectronic sensing technique for the screening of cytoprotective compounds. Int J Mol Med 2010, 25:525-530.
24. Faragó N, Zvara A, Varga Z, Ferdinandy P, Puskás LG: Purification of high-quality micro RNA from the heart tissue. Acta Biol Hung 2011, 62:413-425.
25. Kürti L, Veszelka S, Bocsik A, Dung NT, Ozsvári B, Puskás LG, Kittel A, Szabó-Révész P, Deli MA: The effect of sucrose esters on a culture model of the nasal barrier. Toxicol In Vitro 2012, 26:445-454.
26. Vartak S, Robbins ME, Spector AA: Polyunsaturated fatty acids increase the sensitivity of 36B10 rat astrocytoma cells to radiation-induced cell kill. Lipids 1997, 32:283-292.
27. Das UN: Gamma-linolenic acid, arachidonic acid, and eicosapentaenoic acid as potential anticancer drugs. Nutrition 1989, 6:429-434.
28. Wu Y, Tada M, Takahta K, Tomizawa K, Matsui H: Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells. Acta Med Okayama 2007, 61:147-152.
29. Wang F, Bhat K, Doucette M, Zhou S, Gu Y, Law B, Liu X, Wong ET, Kang JX, Hsieh TC, Qian SY, Wu E: Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis. Curr Mol Med 2011, 11:503-511.
30. Ramos KL, Colquhoun A: Protective role of glucose-6-phosphate dehydrogenase activity in the metabolic response of C6 rat glioma cells to polyunsaturated fatty acid exposure. Glia 2003, 43:149-166.
31. Lu X, Yu H, Ma Q, Shen S, Das UN: Linoleic acid suppresses colorectal cancer cell growth by inducing oxidant stress and mitochondrial dysfunction. Lipids Health Dis 2010, 9:106.
32. Vartak S, McCaw R, Davis CS, Robbins ME, Spector AA: Gamma-linolenic acid (GLA) is cytotoxic to 36B10 malignant rat astrocytoma cells but not to 'normal' rat astrocytes. Br J Cancer 1998, 77:1612-1620.
33. Bell HS, Wharton SB, Leaver HA, Whittle IR: Effects of N-6 essential fatty acids on glioma invasion and growth: experimental studies with glioma spheroids in collagen gels. J Neurosurg 1999, 91:989-996.
34. Liu J, Shimizu K, Kondo R: Anti-androgenic activity of fatty acids. Chem Biodivers 2009, 6:503-512.
35. Soto-Guzman A, Robledo T, Lopez-Perez M, Salazar EP: Oleic acid induces ERK1/2 activation and AP-1 DNA binding activity through a mechanism involving Src kinase and EGFR transactivation in breast cancer cells. Mol Cell Endocrinol 2008, 294:81-91.
36. Lonergan PE, Martin DS, Horrobin DF, Lynch MA: Neuroprotective actions of eicosapentaenoic acid on lipopolysaccharide-induced dysfunction in rat hippocampus. J Neurochem 2004, 91:20-29.
37. Madácsi R, Kanizsai I, Fehér LZ, Gyuris M, Ozsvári B, Erdélyi A, Wölfling J, Puskás LG: Aromatic sulfonamides containing a condensed piperidine moiety as potential oxidative stress-inducing anticancer agents. Med Chem 2013, 9:911-919.
38. Soni D, King JJ, Kaye AH, Hovens CM: Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge. J Clin Neurosci 2005, 12:1-5.
39. Cenci T, Martini M, Montano N, D'Alessandris QG, Falchetti ML, Annibali D, Savino M, Bianchi F, Pierconti F, Nasi S, Pallini R, Larocca LM: Prognostic relevance of c-MYC and BMI1 expression in patients with glioblastoma. Am J Pathol 2012, 138:390-396.
40. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-MYC protein. Cell 1992, 69:119-128.
41. Cury-Boaventura MF, Pompéia C, Curi R: Comparative toxicity of oleic acid and linoleic acid on Jurkat cells. Clin Nutr 2004, 23:721-732.
42. Cury-Boaventura CJ, Pompéia C, Curi R: Comparative toxicity of oleic acid and linoleic acid on Raji cells. Nutrition 2005, 21:395-405.
43. Kim HJ, Vosseler CA, Weber PC, Erl W: Docosahexaenoic acid induces apoptosis in proliferating human endothelial cells. J Cell Physiol 2005, 204:881-888.
44. Takahashi R, Giannini C, Sarkaria JN, Schroeder M, Rogers J, Mastroeni D, Scrable H: p53 isoform profiling in glioblastoma and injured brain. Oncogene 2013, 32:3165-3174.
45. Preuss M, Girnun GD, Darby CJ, Khoo N, Spector AA, Robbins ME: Role of antioxidant enzyme expression in the selective cytotoxic response of glioma cells to gamma-linolenic acid supplementation. Free Radic Biol Med 2000, 28:1143-1156.
46. Maines MD: Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1988, 2:2557-2568.
47. Berberat PO, Dambrauskas Z, Gulbinas A, Giese T, Giese N, Künzli B, Autschbach F, Meuer S, Büchler MW, Friess H: Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 2005, 11:3790-3798.
48. Faragó N, Kocsis ÁK, Lovas S, Molnár G, Boldog E, Rózsa M, Szemenyei V, Vámos E, Nagy LI, Tamás G, Puskás LG: Digital PCR to determine the number of transcripts from single neurons after patch-clamp recording. Biotechniques 2013, 54:327-336.
49. Zhang W, Qiao T, Zha L: Inhibition of heme oxygenase-1 enhances the radiosensitivity in human nonsmall cell lung cancer a549 cells. Cancer Biother Radiopharm 2011, 26:639-645.
50. Gandini NA, Fermento ME, Salomón DG, Obiol DJ, Andrés NC, Zenklusen JC, Arevalo J, Blasco J, López Romero A, Facchinetti MM, Curino AC: Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma. Tumour Biol 2014, 35:2803-2815.
51. Le Calvé B, Rynkowski M, Le Mercier M, Bruyère C, Lonez C, Gras T, Haibe-Kains B, Bontempi G, Decaestecker C, Ruysschaert JM, Kiss R, Lefranc F: Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia 2010, 12:727-739.
52. Lin L, Qin Y, Jin T, Liu S, Zhang S, Shen X, Lin Z: Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma. Exp Mol Pathol 2013, 96:8-13.
53. Okamura T, Kurisu K, Yamamoto W, Takano H, Nishiyama M: NADPH/quinone oxidoreductase is a priority target of glioblastoma chemotherapy. Int J Oncol 2000, 16:2000.
54. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG: NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 2010, 28:5-16.
55. Lu DY, Chang CS, Yeh WL, Tang CH, Cheung CW, Leung YM, Liu JF, Wong KL: The novel phloroglucinol derivative BFP induces apoptosis of glioma cancer through reactive oxygen species and endoplasmic reticulum stress pathways. Phytomedicine 2012, 19:1093-1100.
56. Kardosh A, Golden EB, Pyrko P, Uddin J, Hofman FM, Chen TC, Louie SG, Petasis NA, Schönthal AH: Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethylcelecoxib. Cancer Res 2008, 68:843-851.
57. Lin CJ, Lee CC, Shih YL, Lin CH, Wang SH, Chen TH, Shih CM: Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells. PLoS One 2012, 7:e38706.
58. Pyrko P, Schönthal AH, Hofman FM, Chen TC, Lee AS: The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res 2007, 67:9809-9816.
59. Datta R, Rubin E, Sukhatmet V, Qureshif S, Hallahan D, Weichselbaum RR, Kufe DW: Ionizing radiation activates transcription of the EGRI gene via CArG elements. Proc Natl Acad Sci U S A 1992, 89:10149-10153.
60. Meyer RG, Küpper JH, Kandolf R, Rodemann HP: Early growth response-1 gene (Egr-1) promoter induction by ionizing radiation in U87 malignant glioma cells in vitro. Eur J Biochem 2002, 269:337-346.
61. Cao XM, Koski RA, Gashler A, McKiernan M, Morris CF, Gaffney R, Hay RV, Sukhatme VP: Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Mol Cell Biol 1990, 10:1931-1939.
62. Blaylock RL: Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis. Surg Neurol Int 2013, 4:15.
63. Kesari S, Bota DA: Fos-related antigen-1 (Fra-1) is a regulator of glioma cell malignant phenotype. Cancer Biol Ther 2011, 11:307-310.
64. Shirsat NV, Shaikh SA: Overexpression of the immediate early gene fra-1 inhibits proliferation, induces apoptosis, and reduces tumourigenicity of c6 glioma cells. Exp Cell Res 2003, 291:91-100.
65. Debinski W, Gibo DM: Fos-related antigen 1 modulates malignant features of glioma cells. Mol Cancer Res 2005, 3:237-249.
66. Asuthkar S, Nalla AK, Gondi CS, Dinh DH, Gujrati M, Mohanam S, Rao JS: GADD45A senitizes medulloblastoma cells to irradiation and suppresses MMP-9-mediated EMT. Neuro Oncol 2011, 13:10.
67. Low SY, Ho YK, Too HP, Yap CT, Ng WH: MicroRNA as potential modulators in chemoresistant high-grade gliomas. J Clin Neurosci 2014, 21:395-400.
68. Hou Z, Yin H, Chen C, Dai X, Li X, Liu B, Fang X: microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer. Mol Med Rep 2012, 6:501-506.
69. Catalá A, Zvara A, Puskás LG, Kitajka K: Melatonin-induced gene expression changes and its preventive effects on adriamycin-induced lipid peroxidation in rat liver. J Pineal Res 2007, 42: 43-49.